Long
Updated

SMAR - Healthy outlook ahead

173
SMAR is not yet profitable due to their SG&A as well as R&D related costs - proper of the growth stage the company is currently navigating. Nevertheless, they have healthy financials (gross margin, strong cash position, low debt levels). Overall, the company posted a 69% EPS QoQ increase and a 40% sales increase in the last quarter. In fact, SMAR has an average growth rate of +50% on sales over the last 3y. Current estimates point to a ~40% increase in sales for the FY'2021 (sales growth expectancy remains very high for the years ahead). I see this as a good entry opportunity following the recent sell-off, as there seem to exist some important support levels below.
Trade closed: stop reached
Trade closed as the stop was reached. Keeping an eye on it as the company should achieve profitability soon and invert the trend

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.